Press Release: Sitryx : SITRYX THERAPEUTICS ANNOUNCES PARTICIPATION AT THE LONGWOOD HEALTHCARE LEADERS PRE-JPM WEBCONFERENCE, JANUARY 5TH & JANUARY 6TH, 2023

OXFORD, England, Dec. 21, 2022 /PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that Neil Weir, Chief Executive Officer of Sitryx, will participate in a discussion titled "Early Preparation for...